Ovid Therapeutics Inc. (OVID) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Ovid Therapeutics Inc.

    NASDAQ: OVID · Real-Time Price · USD
    1.84
    0.20 (12.20%)
    At close: Oct 03, 2025, 3:59 PM
    1.84
    0.00%
    Pre-market: Oct 06, 2025, 09:10 AM EDT

    Ovid Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -2.5 -4.34 -2.42 1.76
    PEG Ratio
    		 0.05 1.11 0.02 -0.01
    PS Ratio
    		 116.97 580.22 87.15 1.04
    PB Ratio
    		 0.97 2.59 0.99 1.21
    P/FCF Ratio
    		 -1.18 -4.95 -2.31 1.83
    P/OCF Ratio
    		 -1.18 -4.96 -2.37 1.83
    OCF/S Ratio
    		 -98.86 -116.88 -36.74 0.57
    Debt / Equity Ratio
    		 0.22 0.18 0.13 n/a
    Quick Ratio
    		 5.32 9.55 18.79 12.87
    Current Ratio
    		 5.32 9.55 18.79 12.87
    Asset Turnover
    		 0.01 0.00 0.01 1.07
    Interest Coverage
    		 n/a n/a n/a n/a
    Return on Equity
    		 -0.39 -0.6 -0.41 0.68
    Return on Assets
    		 -0.29 -0.36 -0.35 0.63
    Return on Invested Capital
    		 -0.73 -0.44 -0.37 0.68
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 1.00 1.00 1.00 1.00
    Net Profit Margin
    		 -46.7 -133.62 -36.04 0.59
    Pretax Profit Margin
    		 -46.7 -133.62 -36.04 0.60
    Operating Profit Margin
    		 -109.34 -151.34 -36.96 0.60
    FCF Margin
    		 -98.99 -117.23 -37.69 0.57
    EBITDA Margin
    		 -102.07 -145.55 -36.04 0.60

    Add to Watchlist